Highly immunosuppressive myeloid cells correlate with early relapse after allogeneic stem cell transplantation

Highly immunosuppressive myeloid cells correlate with early relapse after allogeneic stem cell transplantation

Abstract Background Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curative treatment for myeloid malignancies such as some acute myeloid leukemias (AML) and high-risk myelodysplastic syndromes (MDS). It aims to eradicate the malignant clone using immunocompetent donor ce...

Full description

Bibliographic Details
Main Authors: Anne-Béatrice Notarantonio, Allan Bertrand, Romain Piucco, Ghislain Fievet, Hervé Sartelet, Laura Boulangé, Natalia de Isla, Marcelo De Carvalho Bittencourt, Sébastien Hergalant, Marie-Thérèse Rubio, Maud D’Aveni
Format: Article
Language:English
Published: BMC 2024-05-01
Series:Experimental Hematology & Oncology
Subjects:
Allogeneic stem cell transplantation
Relapse
MDSC
Online Access:https://doi.org/10.1186/s40164-024-00516-4

Internet

https://doi.org/10.1186/s40164-024-00516-4

Similar Items